These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9042372)

  • 1. Antisense strategies in dopamine receptor pharmacology.
    Weiss B; Zhang SP; Zhou LW
    Life Sci; 1997; 60(7):433-55. PubMed ID: 9042372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors.
    Weiss B; Davidkova G; Zhou LW; Zhang SP; Morabito M
    Neurochem Int; 1997 Oct; 31(4):571-80. PubMed ID: 9308007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW; Zhang SP; Qin ZH; Weiss B
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B
    Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
    Silvia CP; King GR; Lee TH; Xue ZY; Caron MG; Ellinwood EH
    Mol Pharmacol; 1994 Jul; 46(1):51-7. PubMed ID: 8058056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense strategies in neurobiology.
    Weiss B; Davidkova G; Zhang SP
    Neurochem Int; 1997 Sep; 31(3):321-48. PubMed ID: 9246677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into dopaminergic receptor function using antisense and genetically altered animals.
    Sibley DR
    Annu Rev Pharmacol Toxicol; 1999; 39():313-41. PubMed ID: 10331087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP; Zhou LW; Weiss B
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates.
    Zhang M; Creese I
    Neurosci Lett; 1993 Oct; 161(2):223-6. PubMed ID: 7903803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor genes: new tools for molecular psychiatry.
    Niznik HB; Van Tol HH
    J Psychiatry Neurosci; 1992 Oct; 17(4):158-80. PubMed ID: 1450188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor subtype-specific dopaminergic agents and unconditioned behavior.
    Beninger RJ; Mazurski EJ; Hoffman DC
    Pol J Pharmacol Pharm; 1991; 43(6):507-28. PubMed ID: 1687945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 and D2 dopamine receptor mRNA in rat brain.
    Weiner DM; Levey AI; Sunahara RK; Niznik HB; O'Dowd BF; Seeman P; Brann MR
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1859-63. PubMed ID: 1825729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotides in the study of central mechanisms of the cardiovascular regulation.
    Culman J
    Exp Physiol; 2000 Nov; 85(6):757-67. PubMed ID: 11187969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
    Valerio A; Alberici A; Tinti C; Spano P; Memo M
    J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The molecular biology of dopamine receptors].
    Fujiwara Y; Sora I; Tomita H
    Yakubutsu Seishin Kodo; 1991 Jun; 11(3):187-96. PubMed ID: 1685287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization.
    Shih M; Malbon CC
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12193-7. PubMed ID: 7991605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
    Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
    Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on dopamine receptors.
    Meador-Woodruff JH
    Ann Clin Psychiatry; 1994 Jun; 6(2):79-90. PubMed ID: 7804392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor subtypes colocalize in rat striatonigral neurons.
    Surmeier DJ; Eberwine J; Wilson CJ; Cao Y; Stefani A; Kitai ST
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10178-82. PubMed ID: 1332033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.